Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.39M Buy
63,650
+257
+0.4% +$5.96K 0.04% 154
2025
Q4
$1.48M Buy
63,393
+2,832
+5% +$68.3K 0.04% 147
2025
Q3
$1.69M Buy
60,561
+7,525
+14% +$200K 0.05% 127
2025
Q2
$1.17M Sell
53,036
-616
-1% -$13.5K 0.04% 152
2025
Q1
$1.25M Buy
53,652
+306
+0.6% +$7.82K 0.04% 147
2024
Q4
$1.53M Buy
53,346
+131
+0.2% +$3.92K 0.05% 120
2024
Q3
$1.58M Sell
53,215
-712
-1% -$22.1K 0.06% 119
2024
Q2
$1.82M Sell
53,927
-3,040
-5% -$105K 0.07% 113
2024
Q1
$2.06M Sell
56,967
-86
-0.2% -$2.98K 0.08% 110
2023
Q4
$1.86M Buy
57,053
+1,290
+2% +$39.8K 0.09% 107
2023
Q3
$1.81M Sell
55,763
-2,972
-5% -$95.3K 0.09% 103
2023
Q2
$1.72M Buy
+58,735
New +$1.62M 0.09% 108
2020
Q4
Sell
-3,750
Closed -$102K 309
2020
Q3
$102K Buy
+3,750
New +$99.6K 0.02% 145
2020
Q2
Sell
-3,750
Closed -$87.1K 294
2020
Q1
$87.1K Hold
3,750
0.02% 154
2019
Q4
$113K Hold
3,750
0.03% 191
2019
Q3
$96.9K Buy
+3,750
New +$99.1K 0.03% 175
2019
Q2
Sell
-3,750
Closed -$84.8K 323
2019
Q1
$84.8K Buy
+3,750
New +$78.4K 0.03% 177

Other funds holding GNTX

Advisory Alpha's GNTX Position: Q1 2026 in Review

Advisory Alpha increased its Gentex (GNTX) stake by 0.41% in Q1 2026, buying an estimated $5.96K and bringing the position to 63,650 shares worth $1.39M. The position accounts for 0.04% of the portfolio, ranked #154.

Advisory Alpha first reported a position in GNTX in Q1 2019 and has held it in 17 quarters since. The position peaked at $2.06M in Q1 2024. 501 funds tracked by Wall St. Rank hold GNTX as of Q1 2026.

  • Advisory Alpha held 63,650 shares of Gentex worth $1.39M as of Q1 2026.
  • Advisory Alpha bought 257 Gentex shares in Q1 2026, an estimated $5.96K.
  • Gentex made up 0.04% of Advisory Alpha's portfolio in Q1 2026, its #154 holding.
  • Advisory Alpha first reported a position in Gentex in Q1 2019 and has held it in 17 quarters since.
  • Advisory Alpha's Gentex position peaked at $2.06M in Q1 2024.
  • 501 funds tracked by Wall St. Rank held Gentex as of Q1 2026.

Based on Advisory Alpha's 13F filing for Q1 2026, filed 14 May 2026.